IL-18 (Interleukin-6) / Interferon beta-2 (Hybridoma Growth Factor) Antibody [IL18/7781]

Summary

Four structurally related IL-1 receptor ligands have been described. These include three agonists designated IL-1α, IL-1β and IL-1γ/IL-18 and a specific receptor antagonist, IL-1Rα. IL-1α and IL-1β play critical roles in the regulation of the immune response and inflammation, serving as activators of T and B lymphocytes and NK (natural killer) cells. IL-18 (also referred to as IL-1γ) has been shown to augment the secretion of IFN-γ from T lymphocytes and increase NK cell activity in spleen cells. IL-18 exhibits 19% and 12% identity with IL-1α and IL-1β respectively over the 12 β-strands of the β-trefoil fold domain, which is a signature feature of the IL-1 family. The unusual leader sequence of IL-18 may be analogous to the IL-1β pro-domain which must be cleaved by the serine protease ICE for optimal secretion and biological activity. Originally described as IGIF (IFN-γ-inducing factor), IL-18 is induced by mouse liver subsequent to challenge with lipopolysaccharide (LPS).